The introduction of prostate specific antigen (PSA) testing has resulted in a dramatic increase in early detection of prostate cancer (CaP) and a stage migration such that more men with early stage CaP are now being diagnosed with the disease [1], [2]. The gene discussed is KLK3; the disease is Familial prostate cancer.